Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Semaglutide”

521 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 521 results

Early research (Phase 1)Study completedNCT01766245
What this trial is testing

A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 28
Testing effectiveness (Phase 2)Study completedNCT05537233
What this trial is testing

ADJUnct Semaglutide Treatment in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesObesity
Viral N. Shah 115
Large-scale testing (Phase 3)Looking for participantsNCT06716216
What this trial is testing

BGM0504 in Participants with Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 537
Early research (Phase 1)Study completedNCT04259801
What this trial is testing

First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes

Who this might be right for
Healthy VolunteersOverweightObesity+1 more
Novo Nordisk A/S 152
Large-scale testing (Phase 3)Study completedNCT05040971
What this trial is testing

Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

Who this might be right for
Obesity
Novo Nordisk A/S 207
Testing effectiveness (Phase 2)Study completedNCT06640972
What this trial is testing

Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists

Who this might be right for
TriglyceridesWeight Gain TrajectoryCholesterol, Elevated
Response Pharmaceuticals 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT07059377
What this trial is testing

Semaglutide for Smoking Cessation in Patients With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Nicotine AddictionTobacco Dependence
Ottawa Heart Institute Research Corporation 100
Not applicableStudy completedNCT04972721
What this trial is testing

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial

Who this might be right for
OverweightObesity
Novo Nordisk A/S 3,439
Large-scale testing (Phase 3)Study completedNCT03548987
What this trial is testing

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 902
Large-scale testing (Phase 3)Study completedNCT02827708
What this trial is testing

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 324
Large-scale testing (Phase 3)Study completedNCT05394519
What this trial is testing

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

Who this might be right for
OverweightObesityType 2 Diabetes Mellitus
Novo Nordisk A/S 1,200
Large-scale testing (Phase 3)Looking for participantsNCT07253285
What this trial is testing

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Who this might be right for
OverweightObesity
Novo Nordisk A/S 460
Post-approval studies (Phase 4)Looking for participantsNCT06754163
What this trial is testing

Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

Who this might be right for
Obesity and Obesity-related Medical ConditionsPsychiatric Disorders
St Andrew's Healthcare 20
Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07411378
What this trial is testing

Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.

Who this might be right for
Muscle WastingObesity & OverweightObesity
Biophytis 164
Post-approval studies (Phase 4)Looking for participantsNCT05702931
What this trial is testing

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation

Who this might be right for
HyperglycemiaRenal Transplant Complication Primary Non-FunctionDiabetes
Rigshospitalet, Denmark 104
Post-approval studies (Phase 4)UnknownNCT05322200
What this trial is testing

The POST-ACS Study

Who this might be right for
Diabetes MellitusAcute Coronary SyndromeCoronary Artery Disease
Swansea Bay University Health Board 140
Not applicableLooking for participantsNCT04990024
What this trial is testing

The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide

Who this might be right for
ObesityWeight Loss
American University of Beirut Medical Center 60
Large-scale testing (Phase 3)Study completedNCT03574597
What this trial is testing

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

Who this might be right for
OverweightObesity
Novo Nordisk A/S 17,604
Large-scale testing (Phase 3)Study completedNCT02207374
What this trial is testing

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 601
Load More Results